Compare WCN & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WCN | IQV |
|---|---|---|
| Founded | 1997 | 1982 |
| Country | Canada | United States |
| Employees | N/A | 93000 |
| Industry | Power Generation | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8B | 35.1B |
| IPO Year | 2005 | 2013 |
| Metric | WCN | IQV |
|---|---|---|
| Price | $171.18 | $211.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 16 |
| Target Price | $204.21 | ★ $227.13 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ 74.48 | 4.67 |
| EPS | ★ 2.02 | 1.61 |
| Revenue | $9,466,915,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $6.14 | $6.77 |
| Revenue Next Year | $6.18 | $5.89 |
| P/E Ratio | ★ $83.97 | $129.22 |
| Revenue Growth | 6.14 | ★ 41.60 |
| 52 Week Low | $146.89 | $154.50 |
| 52 Week High | $191.91 | $247.05 |
| Indicator | WCN | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 57.02 | 61.60 |
| Support Level | $168.34 | $206.72 |
| Resistance Level | $173.26 | $212.36 |
| Average True Range (ATR) | 3.08 | 5.45 |
| MACD | -0.66 | -0.85 |
| Stochastic Oscillator | 33.13 | 55.19 |
Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.